UNiD ASI
-
Regulatory
MEDICREA® Announces FDA Clearance of the World’s First Patient-Matched Spinal Interbody Cages
February 11, 2020 LYON, France & NEW YORK–(BUSINESS WIRE)–MEDICREA® (Euronext Growth Paris : FR0004178572 – ALMED, PEA-PME eligible and OTCQX :…
Read More » -
Spine
MEDICREA®’s UNiD® ASI Technology Hits 5,000th Patient-Specific Spine Surgery Milestone With Strong Penetration of the Degenerative and Minimally Invasive Market Segment
February 03, 2020 LYON, France & NEW YORK–(BUSINESS WIRE)–MEDICREA® (Euronext Growth Paris : FR0004178572 – ALMED, PEA-PME eligible and OTCQX :…
Read More » -
Regulatory
MEDICREA® Secures 7 New US Patents Around Its Proprietary Platform Technology UNiD™ ASI And Reinforces Barriers to Entry for Competitors
January 06, 2020 LYON, France & NEW YORK–(BUSINESS WIRE)–The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best…
Read More » -
Regulatory
MEDICREA® Secures Several New Patents to Protect its Proprietary platform technology UNiD ASI
June 17, 2019 LYON, France & NEW YORK–(BUSINESS WIRE)–The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market…
Read More » -
Spine
MEDICREA® Enhances Its Proprietary UNiD ASI™ Service Platform with the Addition of an FDA-Cleared Device Planning and Selection Service
April 18, 2019 LYON & NEW YORK–(BUSINESS WIRE)–The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED; OTCQX Best Market –…
Read More » -
Spine
MEDICREA® Achieves 3,000 Surgery Milestone with UNiD ASI™ and Patient Specific Implants
November 20, 2018 LYON, France & NEW YORK–(BUSINESS WIRE)–The MEDICREA® Group (Euronext Growth Paris: FR0004178572-ALMED ; OTCQX Best Market –…
Read More » -
Spine
Medicrea Partners with Orthopaedic Surgeon in World’s First 360-Degree Personalized Spine Surgery
September 26, 2017 LYON, France & NEW YORK–(BUSINESS WIRE)–The Medicrea Group (Euronext Growth Paris: FR0004178572 – ALMED), pioneering the convergence…
Read More »